Model-Based Population Pharmacokinetic Analysis of Nivolumab in Patients With Solid Tumors
Author:
Affiliation:
1. Bristol-Myers Squibb; Princeton New Jersey USA
Publisher
Wiley
Subject
Pharmacology (medical),Modelling and Simulation
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/psp4.12143/fullpdf
Reference37 articles.
1. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection;Sharpe;Nat Immunol.,2007
2. Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway;Momtaz;Pharmgenomics Pers Med.,2014
3. CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients;Ott;Clin Cancer Res.,2013
4. Programmed death (PD)−1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis;Jurado;J Immunol.,2008
5. In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates;Wang;Cancer Immunol Res.,2014
Cited by 212 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Formulation and Validation of an Extended Sigmoid Emax Model in Pharmacodynamics;Pharmaceutical Research;2024-08-14
2. A novel approach toward the multigram synthesis of a novel Bcl2-specific inhibitor, and evaluation of its biological activity;European Journal of Medicinal Chemistry Reports;2024-08
3. Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained Settings;South Asian Journal of Cancer;2024-07-31
4. Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer;Cancer Chemotherapy and Pharmacology;2024-07-26
5. Model‐based population pharmacokinetic and exposure response analyses for safety and efficacy of nivolumab as adjuvant treatment in subjects with resected oesophageal or gastroesophageal junction cancer;British Journal of Clinical Pharmacology;2024-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3